Third, because KIFC1-positive cases were associated with favorable prognosis in BC treated with atezolizumab, in the future, we will analyze the prognostic value of KIFC1 in immune therapy using immunohistochemistry. The gene discussed is KIFC1; the disease is breast cancer.